Operator
Good day, everyone, and thank you for joining us for this IBAT second quarter fiscal year 2027 earnings conference call and webcast. All lines have been placed in mute to prevent any background noise, and after the speakers prepared remarks, there will be a question and answer session. If you would like to ask a question during that time, simply press star followed by the digit one on your telephone keypad, and if you need to remove yourself from the queue, repeating the steps of star and one will also do so. Thank you. It's now my pleasure to turn the call over to Mr. Brian Siegel with Investor Relations. Welcome, sir.
Thank you. Good morning, everyone, and welcome to our call today. I'm Brian Siegel with Hayden IR. With me today is our interim CEO, Don Bender, who will provide a business update, and CFO, Michael Rutledge, who will review our financial performance. Before we begin, I want to remind everyone that except for historical information, the matters discussed in this presentation are forward-looking statements that involve risks and uncertainties. Words like believe, expect, and anticipate refer to our best estimates as of this call. There can be no assurances that these will actually take place, so our actual future results could differ significantly from these statements. Further information on the company's risk factors is contained in the company's quarterly and annual reports filed on CDAR+, and now with the Securities and Exchange Commission on EDGAR. With that, I'll turn the call over to Don.
Thanks, Brian, and good morning, everyone. I'm going to start by briefly addressing the recent leadership change. I was named the insurance CEO on October 26th and will continue as VP of Technology and Engineering as well. Garrett Galloway is back in his role as SVP of Corporate Development, focused on partnerships, commercial agreements, and financing. I joined IBAT in November 2024, and my background is in chemical process engineering and capital projects. The board believes this background is going to be important in supporting potential customers in evaluating our technology and moving projects toward commercial deployment. Moving to our business, in North America, our discussions with numerous resource owners have led us to evolve our thinking about how to approach this market over the near term. With a couple of exceptions, the resource owners we've held discussions with are not ready for commercial development. The reasons vary, but there's a sequence that they need to work through in order to be able to define the return on investment well enough to bring capital. That means evaluating their brine on-site and within the full flow sheet, working through regulatory requirements, selecting a technology, and only then getting to a final investment decision, also referred to as FID. Some of those steps, permitting, for example, run on their own clock. We talked about a pilot on prior calls, and with this feedback in hand, we've begun the engineering to build a small, transportable plant to help potential customers with their evaluation. It will be a compact unit that we can ship by truck and set up that site quickly and at a much lower cost than our existing demonstration plant. An owner can then run our DLE technology on their own brine in the field instead of sending us samples to test in our lab. That gives them data to reduce the technical risk of extraction and to understand the value they can get out of the resource. We believe it will help move projects toward investment readiness sooner. For us, it means running our technology in the field, not just in our lab, and getting direct access to resources. A handful of North American parties have expressed real interest in the pilot. Another benefit is that it lets a resource owner look at DLE in the context of a full flow sheet. As we've said before, owners are asking for more than a DLE solution. We believe a full flow sheet gives them a single capital stack, and we've been building relationships that can support that. Of course, we will continue to evaluate opportunities to deploy the demonstration plan, but for resource owners today, we will see the pilot as a more efficient first step. To fund the pilot, engineering, and G&A over the next 12 months, we expect to eminently enter into a secure term loan of up to $12 million with our largest investor to carry the company roughly over the next 12 months. We estimate that approximately $4 million of that will go towards the pilot. Michael will go through the details. In the Middle East, together with our partner, we participated in the competitive RFQ process for a commercial demonstration program, but we were not selected. The feedback we received on our technology, our process, and our operating cost was very positive. Because the project is effectively a large pilot, there may be future opportunities, and we're continuing to maintain our relationship in the region. In South America, Insorcia, who is also an IBAT shareholder, continues to evaluate plans for commercial lithium development. Insorcia's affiliates hold the licenses to our technology in Argentina and Chile, and in October, Insorcia has announced a binding letter of intent to acquire additional resources in Argentina, subject to customary closing conditions. Insorcia has said the property would become part of its Cattle One development program and that our GLE technology is central to its strategy. It's an early but encouraging step in the right direction, and we hope to see them close this deal successfully. With that, I'll turn it over to Michael to walk through the numbers and the financing. Thanks, Don.
Unless I note otherwise, all comparisons are the second quarter of fiscal 2027 against the same quarter last year. We remain early in our revenue development. This quarter, we recognize no service revenue from Bryan testing. Operating costs, excluding depreciation, Remain flat at roughly half a million dollars. SG&A excluding depreciation came down to $1.6 million from $2.2 million in the prior year. Our operating loss narrowed to $2.9 million from $3.4 million, an improvement of roughly $500,000 as we ran the business leaner and certain costs from last year did not repeat. Each quarter we record a non-cash change in our warrant liability based on updated pricing calculations. This quarter, we experienced a gain of $5 million compared to a gain of $8.8 million in the prior year. These fluctuations will continue until the outstanding warrants are exercised or expire. Net income came in at $2.2 million compared to a net income of $3.0 million last year, both representing a penny per share. We ended the quarter with $7.4 million in cash, compared to $9.2 million at the end of March, and we carried no debt. As Don mentioned, we do plan on entering into a secured 18-month term loan agreement with our largest shareholder for up to $12 million, subject to compliance with certain companies. We expect that approximately $4 million of it will be used to fund the pilot plant, and we expect to be able to access a remainder on a quarterly basis to fund general and administrative expenses. With the cash on hand at quarter end, plus access to the impending term loan, we believe we have sufficient operating cash to continue through at least the next 12 months, and we have a solid balance sheet to fund our ongoing operations.
With that, we'll take questions now.
Operator
And to our audience joining today over the phones, if you would like to ask a question, simply press star followed by the digit 1 on your telephone keypad. Pressing star on 1 will also remove you from the queue if you find that your question has been asked.
Operator
And we'll pause for a moment to assemble our roster on the phone side. Presently, no signals from our phone side, gentlemen. All right.
Well, thank you very much for your attendance today, and we look forward to communicating with you in the future.
Operator
Ladies and gentlemen, this does conclude the IBAT second quarter fiscal year 27 earnings conference call and webcast. We thank you all for your participation. You may now disconnect your lines.